ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Smith and Nephew PLC

Smith and Nephew PLC (NPW1)

11,50
-0,045
( -0,39% )
Aktualisiert: 20:19:02
Echtzeitdaten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
11,50
Gebot
11,625
Fragen
11,705
Volumen
800
11,50 Tagesbereich 11,625
11,035 52-Wochen-Bereich 14,88
Handelsende
11,545
Handelsbeginn
11,625
Letzte Trade
400
@
11.5
Letzter Handelszeitpunkt
15:43:59
Durchschnittliches Volumen (3 Mio.)
585
Finanzvolumen
-
VWAP
-

NPW1 Neueste Nachrichten

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery Patented technology further personalizes total knee arthroplasty for surgeons and patients...

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility Smith+Nephew (LSE:SN, NYSE:SNN), the global medical...

Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers

Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces an exclusive...

Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System

Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System Engineered for precision, confidence and efficiency in surgery - and compatible with...

Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board

Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board Smith+Nephew (LSE:SN, NYSE:SNN), the global medical...

Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game

Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game Smith+Nephew (LSE:SN, NYSE:SNN), the...

Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System

Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System...

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention  

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention   Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is...

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.025-0.21691973969611.52511.62511.035109011.3722367DE
4-1.78-13.403614457813.2813.7611.035100711.85599645DE
12-2.545-18.120327518714.04514.5211.03558512.46578173DE
26-0.585-4.8407116259812.08514.8811.03558112.61193082DE
52-0.37-3.1171019376611.8714.8811.03552412.44940309DE
156-1.09-8.6576648133412.5914.8810.26549112.34327231DE
260-1.09-8.6576648133412.5914.8810.26549112.34327231DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NL8Genesis Ai Corp
0,0182 €
(51,67%)
9k
48QX4 Pharmaceuticals Inc
0,39 €
(51,28%)
19,69k
3O8Omeros Corporation
6,00 €
(51,06%)
25,55k
AMIMedondo Holding AG
0,645 €
(36,65%)
10,82k
PI3Gubra AS
87,60 €
(34,77%)
68,96k
BVU3St James Gold Corp
0,0665 €
(-40,63%)
1,2k
AXIAtos SE
0,1889 €
(-38,73%)
718,6k
BDDConico Ltd
0,0004 €
(-33,33%)
250k
CNWCodon AG
0,007 €
(-30,00%)
10,38k
7FJQuebec Innovative Materials Corp
0,10 €
(-25,37%)
27,5k
POQ88 Energy Limited
0,001 €
(-16,67%)
8M
D7GNel ASA
0,2999 €
(0,13%)
2,99M
DRHDroneShield Limited
0,4635 €
(-6,27%)
2,59M
2OZAMicrovast Holdings Inc
0,7122 €
(-7,34%)
1,5M
BAYNBayer AG
20,505 €
(1,69%)
1,3M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock